Arthropod-borne viruses (arboviruses), such as dengue and Zika viruses, transmit widely across the globe, posing threats to ...

A drug that is already in clinical trials against hepatitis C virus can also prevent hepatitis E virus from replicating.

Around 70,000 people die each year from infections with the hepatitis E virus. There is currently neither a vaccine nor a ...

Gene and cell therapy is moving fast – and in a clear direction. Programs are pushing toward more complex payloads, virus-free engineering, and manufacturing models that can scale from early research ...

Scientists have discovered a defensive method of cells that resembles Spiderman shooting his web to ensnare enemies. These ...

Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® ...

According to a new study, the herpes simplex virus partially liquefies the densely packed, gel-like core of human cell nuclei to duplicate itself more quickly.

Discovered in 1964 by Anthony Epstein, Yvonne Barr, and Bert Achong, the Epstein-Barr virus (EBV) has intrigued tumor virologists due to its unique behavior. Typically, EBV establishes a lifelong, ...

Herpes simplex virus partially liquefies the tightly packed, gel-like interior of human cell nuclei to copy itself faster, a new study shows. The research centers on how the nucleus of each human cell ...

Herpes simplex virus partially liquifies the tightly packed, gel-like interior of human cell nuclei to copy itself faster, a new study shows.

Detailed price information for Cocrystal Pharma Inc (COCP-Q) from The Globe and Mail including charting and trades.

Though Gilead Sciences made waves last June with a landmark FDA approval for its twice-yearly HIV preventive Yeztugo (lenacapavir), the first-in-class drug had previously been used as a long-acting ...